▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Should Dividend Investors Eject Pfizer Inc?

By Dave Williamson – Jun 25, 2014 at 5:35PM

It's a dividend showdown, World Cup style!

Pfizer (PFE -1.88%) has one of the biggest dividends in health care; but does that make it one of the sector's top dividend stocks?

In this video, Motley Fool health-care analyst David Williamson will be grading well-known dividend stocks using a World Cup inspired grading system: A yellow card is a warning for investors, a red card is an ejection, and a "goal" happens if the stock looks like a winner.

Watch and find out the current strengths and weaknesses of Pfizer, and if it should be ejected by investors.

David Williamson owns shares of Pfizer and Zoetis. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services